Shaukat N, Lear J, Lowy A, Fletcher S, de Bono D P, Woods K L
Department of Medicine and Therapeutics and Public Health, University of Leicester.
BMJ. 1997 Mar 1;314(7081):639-42. doi: 10.1136/bmj.314.7081.639.
To compare long term outcome after first myocardial infarction among British patients originating from the Indian subcontinent and from Europe.
Matched pairs study.
Coronary care unit in central Leicester.
238 pairs of patients admitted during 1987-93 matched for age (within 2 years), sex, date of admission (within 3 months), type of infarction (Q/non-Q), and site of infarction.
Incidence of angina, reinfarction, or death during follow up of 1-7 years.
Patients of Indian subcontinent origin had a higher prevalence of diabetes (35% v 9% in patients of European origin, P < 0.001), lower prevalence of smoking (39% v 63%, P < 0.001), longer median delay from symptom onset to admission (5 hours v 3 hours, P < 0.01), and lower use of thrombolysis (50% v 66%, P < 0.001). During long term follow up (median 39 months), mortality was higher in patients of Indian subcontinent origin (unadjusted hazard ratio = 2.1, 95% confidence interval 1.3 to 3.4, P = 0.002). After adjustment for smoking, history of diabetes, and thrombolysis the estimated hazard ratio fell slightly to 2.0 (1.1 to 3.6, P = 0.02). Patients of Indian subcontinent origin had almost twice the incidence of angina (54% v 29%; P < 0.001) and almost three times the risk of reinfarction during follow up (34% v 12.5% at 3 years, P < 0.001). The unadjusted hazard ratio for reinfarction in patients of Indian subcontinent origin was 2.8 (1.8 to 4.4, P < 0.001). Adjustment for smoking, history of diabetes, and thrombolysis made little difference to the hazard ratio. Coronary angiography was performed with similar frequency in the two groups; triple vessel disease was the commonest finding in patients of Indian subcontinent origin and single vessel disease the commonest in Europeans (P < 0.001).
Patients of Indian subcontinent origin are at substantially higher risk of mortality and of further coronary events than Europeans after first myocardial infarction. This is probably due to their higher prevalence of diffuse coronary atheroma. Their need for investigation with a view to coronary revascularisation is therefore greater. History of diabetes is an inadequate surrogate for ethnic origin as a prognostic indicator.
比较源自印度次大陆和欧洲的英国患者首次心肌梗死后的长期预后。
配对研究。
莱斯特市中心的冠心病监护病房。
1987年至1993年间收治的238对患者,按年龄(相差2岁以内)、性别、入院日期(相差3个月以内)、梗死类型(Q波/非Q波)和梗死部位进行配对。
1至7年随访期间心绞痛、再梗死或死亡的发生率。
印度次大陆裔患者糖尿病患病率较高(35%,而欧洲裔患者为9%,P<0.001),吸烟率较低(39%对63%,P<0.001),从症状发作到入院的中位延迟时间较长(5小时对3小时,P<0.01),溶栓治疗使用率较低(50%对66%,P<0.001)。在长期随访(中位39个月)中,印度次大陆裔患者的死亡率较高(未调整的风险比=2.1,95%置信区间1.3至3.4,P=0.002)。在对吸烟、糖尿病史和溶栓治疗进行调整后,估计风险比略有下降,降至2.0(1.1至3.6,P=0.02)。印度次大陆裔患者心绞痛发生率几乎是欧洲裔患者的两倍(54%对29%;P<0.001),随访期间再梗死风险几乎是欧洲裔患者的三倍(3年时为34%对12.5%,P<0.001)。印度次大陆裔患者再梗死的未调整风险比为2.8(1.8至4.4,P<0.001)。对吸烟、糖尿病史和溶栓治疗进行调整后,风险比变化不大。两组进行冠状动脉造影的频率相似;三支血管病变在印度次大陆裔患者中最常见,单支血管病变在欧洲裔患者中最常见(P<0.001)。
印度次大陆裔患者首次心肌梗死后的死亡风险和进一步发生冠状动脉事件的风险显著高于欧洲裔患者。这可能是由于他们弥漫性冠状动脉粥样硬化的患病率较高。因此,他们对冠状动脉血运重建检查的需求更大。糖尿病史作为预后指标,不能充分替代种族作为预后指标。